|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MONTREAL , May 4, 2018 /CNW Telbec/ - BioAmber Inc. (BIOA) ("Bioamber" or the "company") announces today that it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code and that its two Canadian subsidiaries, BioAmber Sarnia Inc. and BioAmber Canada Inc., filed a Notice of Intention (the "NOI") to make a proposal under the Bankruptcy and Insolvency Act ( Canada ), with a view to strengthening the company's financial health and solidifying its long-term business prospects. BioAmber believes filing these procedures is the best way to protect all stakeholders and will best facilitate its efforts to renegotiate its debt and raise the funds needed to continue its operations. The filing of these procedures has the effect of imposing an automatic stay of proceedings that will protect the company, its Canadian subsidiaries and their assets from the claims of creditors while the company pursues its restructuring efforts.
MONTREAL , May 1, 2018 /CNW Telbec/ - BioAmber Inc. (BIOA) announced today that its Special Meeting of Stockholders scheduled for and convened on April 27 th, 2018 (the "Special Meeting"), was adjourned, with the adjournment itself being the only business conducted at the meeting. The adjournment is to allow for the solicitation of additional votes in favour of the proposals contained in the proxy statement that BioAmber filed with the Securities and Exchange Commission on March 30, 2018 , as amended on April 16, 2018 , (i) to increase its authorized shares of common stock from 250,000,000 to 1,000,000,000, and (ii) to approve a reverse stock split at a ratio of not less than fifty-to-one and not more than three-hundred-to-one, such ratio and the implementation and timing of such reverse stock split to be determined in the discretion of its Board of directors, it being understood that upon such implementation of the reverse stock split, the number of authorized shares of common stock will be reduced proportionally based on the reverse stock split ratio.
MONTREAL, March 27, 2018 /PRNewswire/ - BioAmber Inc. (BIOA) announced that it has scheduled a webcast and conference call for 8:00 am (EDT), Wednesday, March 28th, to discuss the fourth quarter and year end 2017 results. An audio replay of the call will be available approximately two hours after the conclusion of the live call, and will remain available on BioAmber's website until April 4th, 2018. BioAmber (BIOA) is a renewable materials company.
MONTREAL , March 27, 2018 /PRNewswire/ - BioAmber Inc. (OTCPK: BIOA) today announced operational and financial results for the three months and year ended December 31, 2017 . Q4 2017 Highlights: The fourth ...
NEW YORK, NY / ACCESSWIRE / March 16, 2018 / BioAmber, Inc. OTC PINK: BIOA ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 16, 2018, at 8:00 AM Eastern Time. To ...
MONTREAL, March 15, 2018 /PRNewswire/ - BioAmber Inc. (BIOA) (the "Company") announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission (the "SEC") regarding a delay in the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (the "Annual Report") because of the additional time that the Company's independent auditors require to complete their audit of the Company's financial statements for the fiscal year ended December 31, 2017. The Company intends to file its Annual Report within the fifteen-day extension period provided by Form 12b-25 and continues to work diligently to finalize its financial statements. Given the ongoing audit of the Company's financial statements by the Company's independent auditors and its audit committee, the Company announced that it is postponing its fourth quarter and full year 2017 earnings release and conference call, previously scheduled for March 15, 2018 and March 16, 2018, respectively, until such audit is completed and the Company has filed its Annual Report.
BioAmber Delays Filing of Annual Report on Form 10-K and Postpones Earnings Release and Conference Call for Fourth Quarter and Full Year 2017
Aqua Concept GmbH Launches coracon® LT EKO, a Performing and Sustainable Heat Transfer Fluid Engineered from BioAmber's Bio Succinic Acid
MONTREAL, March 13, 2018 /PRNewswire/ - aqua concept GmbH announces the launch of coracon® LT EKO, an innovative and environmentally friendly family of liquid coolants based on BioAmber's bio-succinic acid. Marketed as antifreeze or brine, coracon® provides several performance advantages over existing alternatives such as: low viscosity, high pumpability, very low freezing temperatures, remarkable thermo-physical and heat exchange properties, food approval and high corrosion protection. "Since aqua concept was founded, providing the best-in-class solutions while working to protect the environment has been a central theme in our company's culture.
MONTREAL, March 12, 2018 /PRNewswire/ - BioAmber Inc. (BIOA) announced that it will report financial results for the fourth quarter 2017 on Thursday, March 15th, 2018 after markets close. An audio replay of the call will be available approximately two hours after the conclusion of the live call, and will remain available on BioAmber's website for 5 days. BioAmber (BIOA) is a renewable materials company.
NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
MONTREAL, Feb. 16, 2018 /PRNewswire/ - BioAmber Inc. (BIOA) announced today that the Toronto Stock Exchange (TSX) has notified the Company that it has determined to suspend trading in the Company's shares of common stock, effective February 16, 2018, and to delist the Company's securities effective at the close of market on March 16, 2018.
MONTREAL, Feb. 13, 2018 /PRNewswire/ - BioAmber Inc. (BIOA) announced today that the Toronto Stock Exchange (TSX) has notified the Company that it is reviewing, on an expedited basis, the Company's eligibility for continued listing. This review results from the Company not being in a position to obtain the approval of the TSX in connection with its registered direct offering announced on February 9, 2018. BioAmber was notified of the listing review on February 12, 2018.
MONTREAL , Feb. 9, 2018 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) (TSX: BIOA) ("BioAmber" or the "Company"), announced today that it has entered into definitive agreements with certain ...
BioAmber Inc. Announces Registered Direct Offering; Termination of Underwriting Agreement for Previously-Announced Public Offering
MONTREAL, Feb. 6, 2018 /PRNewswire/ - BioAmber Inc. (BIOA) (BIOA) ("BioAmber" or the "Company") announced today that it has priced an underwritten public offering of an aggregate of 40 million Series A units (or equivalent Series B Units), with each Series A unit consisting of one share of common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to purchase one share of common stock, and each Series B unit consisting of one pre-funded warrant to purchase one share of common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to purchase one share of common stock, at a price to the public of US$0.25 per Series A unit and US$0.24 per Series B unit.
BioAmber Inc (NYSE:BIOA) is a small-cap stock with a market capitalization of $20.90M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they endRead More...